New York Life Investment Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-86,748
Closed -$2M 817
2025
Q4
$2M Buy
86,748
+3,266
+4% +$84.2K 0.02% 524
2025
Q3
$2.24M Buy
+83,482
New +$1.99M 0.02% 527

Other funds holding STAA

New York Life Investment Management's STAA Position: Q1 2026 in Review

New York Life Investment Management sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 86,748 shares — an estimated $2M sold.

New York Life Investment Management first reported a position in STAA in Q3 2025 and held it in 2 quarters. The position peaked at $2.24M in Q3 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • New York Life Investment Management reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
  • New York Life Investment Management sold 86,748 STAAR Surgical shares in Q1 2026, an estimated $2M.
  • New York Life Investment Management first reported a position in STAAR Surgical in Q3 2025 and held it in 2 quarters.
  • New York Life Investment Management's STAAR Surgical position peaked at $2.24M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.